Friday, May 15, 2020

Global Non-Invasive Fat Reduction Market: Savvy Players Spend On Brand Awareness To Up Sales, Observes Tmr

Global Non-invasive Fat Reduction Market: Snapshot
The global non-invasive fat reduction market is consolidated owing to a few players holding a substantial share in it. Prominent names in the market have established a stronghold by expanding their geographical outreach by offering multiple non-invasive fat reduction devices. Keen players are also seen growing their marketing spends in order to build solid brand awareness and subsequently attract more customers. Besides, emerging players in the market are seen contributing majorly to its growth.
Serving to drive demand in the global non-invasive fat reduction market is the alarming rise in obesity and health hazards posed by them. This has resulted in people increasingly going for fat reduction and body contouring both through non-invasive and surgical procedures. Demand for better products which are easier to use and yield faster results has resulted in manufacturers focusing on research and development of innovative products. This is also having a positive influence on the market.
A report by Transparency Market Research predicts the global non-invasive fat reduction market to rise at a CAGR of 15.9% CAGR from 2017 to 2025 to become worth US$2.50 bn by 2025 from US$693.2 mn in 2016.
global non invasive fat reduction market
Cryolipolysis Devices See Maximum Demand due to their Different Uses
The different types of non-invasive fat reduction technologies in the market are ultrasound, cryolipolysis, radiofrequencies, low level lasers, etc. Among them, the segment of cryolipolysis led the market with maximum share in 2016 on account of their widespread uptake by doctors, aesthetic surgeons, dermatologists, patients, etc. Cryolipolysis devices are mostly preferred by them over other devices owing to their exhaustive usage pattern. These non-invasive fat reduction energy based devices often use a combination of energy types in order to provide the most effective therapy.
Besides fat reduction, cryolipolysis devices are also commonly used for skin and hair treatments such as removal of pigmented lesions, tattoo removal, skin rejuvenation, etc. As patients increasingly demand noninvasive treatment options, aesthetic providers are increasingly seeing the addition of these products as an essential addition to their suite of offerings.
Depending upon end-users, the key segments of the global non-invasive fat reduction market are hospitals, dermatology clinics, and cosmetic centers. Of them, hospitals hold maximum share in the market since they provide easy access to competent physicians who are adept at conducting a wide array of medical aesthetic fat reduction treatments.
Presence of Numerous Players Focused on Product Development Propels North America Market
Geographically, North America dominates the global non-invasive fat reduction market because of the unveiling of new products every now and then by well-established and upcoming manufacturers domiciled in the region. In addition, the higher spending capacity of people is also proving beneficial to the market in the region. By clocking a CAGR of 15.4% between 2017 and 2025, the market in North America is expected to pull in revenues to the tune of US$1.357 bn by 2025 and retain its dominant share as well.
Europe trails North America in terms of market size. By rising at 16.9% over the forecast period, the region is expected to continue being in the second position in the years ahead too. Vis-à-vis growth rate, Asia Pacific is expected to outshine all other regions by registering a robust CAGR of 18.1% from 2017 to 2025 on the back of increasing disposable incomes and better availability of aesthetic procedures.
Some of the key players in the global non-invasive fat reduction market are Fosun Pharmaceutical Co., Ltd., Cutera, Inc., Cynosure, Inc., ZELTIQ Aesthetics, Inc., and Syneron Medical Ltd.
More Trending Reports by Transparency Market Research –  https://www.biospace.com/article/respiratory-virus-infection-drugs-market/

Dermatology Clinics To Account For Over Two-Third Revenue Share Of Global Non-Surgical Skin Tightening Market In 2017

Non-surgical skin tightening is a minimally invasive procedure where targeted energy is used for heating deeper layers of skin to stimulate elastin and collagen production, which in turn gradually improves the skin tone and texture. Various types of products such as laser-based devices, RF devices, and ultrasound devices are available in the market for carrying out the procedure of non-surgical skin tightening.
Dermatologists Prefer Non-Surgical Skin Tightening Devices over More Invasive Ones
Skin tightening procedures have gained immense popularity over the past few years, with the introduction of a non-surgical alternative to invasive procedures to correct the skin laxity and improve the skin quality. With aging, a large number of people are bothered by the sagging skin on their face, neck and body, which has resulted into high demand for pain-free skin tightening treatments. On the back of low risk involved, dermatologists are preferring non-surgical skin tightening devices over more invasive ones. The easy-to-use non-surgical skin tightening devices help doctors in safely delegating treatment to medical professionals or nurses. A key opportunity for growth of the global non-surgical skin tightening market is the development of more efficient, reliable and advanced devices.
However, results of non-surgical skin tightening procedures are discerned gradually over many weeks or even months following the treatment. Multiple treatments are required for achieving desired results. For maintaining the intended results on the skin, treatments are required to be repeated periodically. In addition, non-surgical skin tightening procedures are not much effective on higher intensity of skin sagging, such as stretched skin or pronounced jowling following weight loss or pregnancy. A recently published research report by Transparency Market Research (TMR) has projected the global non-surgical skin tightening market to reflect an impressive expansion over the forecast period (2017-2022). The report estimates revenues from the market to reach nearly US$ 500 Mn by 2022-end.
non surgical skin tightening market
Non-Surgical Skin Tightening Market to Remain Most Lucrative in North America
The non-surgical skin tightening market will remain the most lucrative in North America, and is estimated to expand at the highest CAGR through 2022. This region is expected to account for the largest share of the global market during 2017 to 2022. The rapid expansion of the market and availability of advanced devices for skin tightening in North America is mainly because of approval for these devices by the FDA. The U.S. recorded highest number of non-surgical skin tightening procedures in the region.
Europe and Asia-Pacific excluding Japan (APEJ) are also anticipated to account for a major revenue share of the global market for non-surgical skin tightening during the forecast period. In contrast, Japan and Middle East and Africa will continue to account for the lowest market revenue shares of the market in the foreseeable future.
Laser-based Devices to be Sought-after among Products
Laser-based devices are expected to be sought-after among products of non-surgical skin tightening procedures, with revenues poised to account for over half share of the global market during 2017 to 2022. RF devices are projected to emerge as the fastest expanding product in the market through 2022. However, revenues from ultrasound devices will remain relatively higher than those from RF devices, although their sales are projected to register a relatively lower CAGR than all the other product segments during the forecast period.
Although, dermatology clinics will remain the largest end-users of non-surgical skin tightening products in terms of revenues, sales in beauty clinics will exhibit a comparatively higher CAGR through 2022.
Company Profiles
TMR’s report profiles key players, who are actively contributing to growth of the global market for non-surgical skin tightening, which include Alma Lasers, Ltd., Fotona d.d., Sciton, Inc., Venus Concept Canada Corp., EL.En. S.p.A., Lynton Lasers Ltd., Lumenis Ltd., Solta Medical Inc., Strata Skin Sciences, Inc., Cynosure, Inc., Lutronic Corporation, and Cutera Inc.
More Trending Reports by Transparency Market Research – 

Global Ophthalmic Surgical Technologies Market To Register 5.80% Cagr Between 2017 And 2022

Global Ophthalmic Surgical Technologies Market: Snapshot
The global ophthalmic surgical technologies market is a growing market thanks to the rising investment flooding into the healthcare sector at present. The ophthalmic surgical technologies market has exhibited rapid growth in the recent past and is likely to continue a steady growth trajectory in the coming years on the back of a favorable financial and regulatory situation. The increasing funding in the healthcare sector has enabled steady product development in the global ophthalmic surgical technologies market, which has further led to improved growth prospects for the market in the near future. The ophthalmic surgical technologies market has thus emerged as a promising market for players across the economic spectrum, with the leading players likely to enjoy steady growth in revenue in the coming years.
The global ophthalmic surgical technologies market is likely to grow to a valuation of US$1,290.5 mn by 2022, exhibiting a 5.8% CAGR in its rise from its 2017 valuation of US$973.4 mn.
ophthalmic surgical technologies market
Femtosecond Systems Likely to Dominate Ophthalmic Surgical Technologies Market
By product type, the global ophthalmic surgical technologies market is segmented into femtosecond systems, excimer laser systems, YAG laser systems, phacoemulsification systems, and others. Of these, femtosecond systems are likely to dominate demand from the global ophthalmic surgical technologies market in the coming years. Femtosecond systems held a total valuation of US$286 mn in 2017, representing 27.3% of the global ophthalmic surgical technologies market. Exhibiting a 5.2% CAGR, the femtosecond systems segment is likely to rise to US$369.3 mn by 2022.
North America to Dominate Geographical Classification of Ophthalmic Surgical Technologies Market
Geographically, North America is likely to be the leading contributor to the global ophthalmic surgical technologies market in the coming years. The North America ophthalmic surgical technologies market is likely to grow from US$372.6 mn to US$501.4 mn over the 2017-2022 forecast period. The market’s robust 6.1% CAGR over the 2017-2022 forecast period is aided by the strongly favorable economic and regulatory framework in place in the healthcare sector in countries such as the U.S. and Canada and is likely to enable sustained dominance of North America in the global ophthalmic surgical technologies market in the coming years.
By end use, hospitals and eye care centers are likely to remain the leading category of the global ophthalmic surgical technologies market in the coming years, dominating ASCs due to the increasing awareness about the importance of eye care.
APEJ to Exhibit Steady Growth, Europe’s Share to Decline
Europe and Asia Pacific except Japan (APEJ) are likely to remain leading contributors to the global ophthalmic surgical technologies market in the coming years, though the two are expected to face contrasting fortunes. The Europe market for ophthalmic surgical technologies is likely to rise to US$372.6 mn by 2022, but will likely suffer from a drop in its market share due to its projected 5.5% CAGR over the 2017-2022 forecast period. The APEJ market for ophthalmic surgical technologies, on the other hand, is likely to exhibit a strong 6% over the 2017-2022 forecast period to emerge with a valuation of US$193 mn.
Japan is also likely to remain a key contributor to the global ophthalmic surgical technologies market in the coming years, and is expected to exhibit a strong 5.7% CAGR in the 2017-2022 forecast period to emerge with a valuation of US$112 mn.
Competitive Dynamics
Leading companies in the global ophthalmic surgical technologies market include Hoya Corporation, Johnson and Johnson, Topcon Corporation, Essilor, Nidek, STAAR Surgical, Alcon Laboratories, Bausch & Lomb Inc., and Carl Zeiss Meditek AG.

Stretch Marks Treatment Market To Expand At 5.40% Cagr By 2024-End Due To Rising Attention Toward Personal Aesthetics

Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women, along with the wide array of products, catering to almost every need and budget, is also positively influencing the market for stretch marks treatment.
A report by Transparency Market Research projects the global stretch marks treatment market to attain a value of US$1.99 bn by 2025-end by clocking a CAGR of 5.40% from 2017 to 2025.
global-stretch-marks-treatment-market.jpg
Topical Products See Maximum Uptake Due to Affordability
Depending upon treatment, the global stretch marks treatment market can be categorized into topical products, lasers, microdermabrasion, etc. Overall, the topical products segment account for a dominant share in the market owing to their affordability and easy availability through various distribution channels. Soaring popularity of ecommerce in particular has proved extremely beneficial to the topical products, which can be further divided into creams, oils and serum, lotions, etc. Of them, the segment of creams is seeing maximum uptake and is said to be majorly fuelling growth in the stretch marks treatment market. The lasers segment again can be divided into fractional lasers, pulse-dye lasers, etc.
Hospitals, clinics, specialty dermatology centers, home-use, etc. are some of the main end-use segments in the global stretch marks treatment market. Among them, the home-use segment accounts for a leading position, and is expected to retain its position in the near future because of the easy availability of home-use products and changing customer preferences. Specialty dermatology centers, on the other hand, are expected to surpass all others vis-à-vis growth rate because of the increasing customer preference for specialists offering expert advice on dermatology procedures.
Increasing Concerns Over Aesthetics Catapults North America Market to Fore
From a geographic standpoint, North America holds a dominant share in the global market for stretch marks treatment. Rising at 5.2% from 2017 to 2025, the market is expected to grow its dominant share further by clocking an estimated revenue of US$676.3 mn by 2025. Increasing consciousness about aesthetics and fashion, coupled with strong ability to spend among people are majorly fuelling the market in the region. The U.S. is said to be powering the market in North America. Europe trails North America in terms of market share. The market in the region is predicted to pull in revenues to the tune of US$531.7 mn by 2025 by registering a CAGR of 5.6% in the forecast period.
In terms of growth rate, Asia Pacific is expected to emerge as a frontrunner by clocking a 5.8% CAGR between 2017 and 2025. At the forefront of driving growth in the market in the region are countries of India and Japan. Effective marketing strategies, changing lifestyles, and most importantly increasing disposable incomes of people are the main drivers of growth in the stretch marks treatment in Asia Pacific.
Prominent participants in the global stretch marks treatment market include Laboratoires Expanscience, Clarins Group, Merz North America, Inc., Cynosure, Inc., Syneron Medical Ltd., E.T. Browne Drug Co., Inc., Union-Swiss (Pty) Ltd., Basq Skincare, Ellipse A/S, The Boppy Company LLC, Helix BioMedix, Inc., Weleda AG, Dermaclara, Inc., Mama Mio US, Inc., and Centre Light Solutions, LLC.

Key Facts About The Tattoo Removal Devices Market: Read More Below

Global Tattoo Removal Devices Market: Snapshot
Various tattoo removal devices are witnessing rising demand among adult populations of all ages for the partial or complete removal of tattoo pigments. The demand for dermatology aesthetics is gaining traction in various emerging and developed economies, which in turn has propelled the demand for tattoo removal technologies. The rising need for multicolor tattoo removal that can remove a wide range of pigments for various skin types with minimal discomfort has bolstered the demand for more efficacious devices. Advancements in tattoo removal technologies has led to safe tattoo treatments in less number of sessions, thereby boosting the uptake. Furthermore, the use of better tattoo inks and dermal clearing agents is expected to boost the outcome of tattoo removal devices. The growing adoption of tattoo removal devices in dermatology clinics in numerous developed and developing nations is a significantly trend that augurs well for the market. The market is witnessing the prominence of laser-based tattoo removal devices that can generate potentially high energy and enable large areas of tattoo pigments to be treated.
The tattoo removal devices market stood at US$219.1 Mn in 2016 and is projected to be worth US$321.9 Mn by 2022 end. The market is anticipated to expand at a CAGR of 6.7% during 2017 – 2022.
tattoo removal devices market
Laser-Based Devices Anticipated to be Most Attractive Segment
The various product types of tattoo removal devices are laser-based devices, RF devices, and ultrasound devices. Of these, the laser-based tattoo removal devices segment holds the dominant share and is expected to witness prominent demand throughout the forecast period. The segment is forecast to generate US$ 142.6 Mn in the global market, accounting for the leading share of 61.3% by 2017 end. Rising at a CAGR of 6.4% during 2017–2022, the segment will reach a valuation of US$194.6 Mn by 2022 end, representing a share of 60.5% in the market. The annual growth of the segment is pegged annually at US$10.4 Mn over 2017–2022. The dominance of the segment is attributed to an extensive demand for these devices world over for populations of all skin types. Substantial technology advancements in laser-based devices are further fueling the growth of the segment during the forecast period.
North America to Provide Most Lucrative Avenues throughout Forecast Period
The various regional markets for tattoo removal devices are North America, Latin America, the Middle East and Africa, Asia Pacific excluding Japan, Japan, and Europe. Of these, North America is predicted to stay ahead of the pack, holding the major revenue share of the global market. The regional market is projected to rise from US$79.9 Mn in 2017 to reach US$114 Mn by 2022 end.  The North America market is projected to rise at a CAGR of 7.4% during 2017–2022. The burgeoning demand for laser-based tattoo removal devices in various parts of the region is a key factor fueling the growth of the regional market.
Europe Market to Rise at Promising Pace 
Europe is a promising market for tattoo removal devices and the regional market holds a significant share of 26%, vis-à-vis revenue, by 2017 end. The revenue of the regional market will increase by at almost three times from 2017 to 2022. However, the share of the segment is likely to decline by 68 BPS in its market share by the end of the forecast period.
Competitive Analysis
Some of the key players operating in the tattoo removal devices market are Alma Lasers, Ltd., Fotona d.d., Sciton, Inc., EL.En. S.p.A., Lynton Lasers Ltd., Solta Medical Inc., Lumenis Ltd., Cynosure, Inc., Syneron Medical Ltd., Lutronic Corporation, and Cutera Inc. Several companies are focused on developing advanced devices that enable fast and the safe removal of a variety of tattoo inks, in order to stay ahead of others.

Thursday, May 14, 2020

Cerebral Oximeters Market:Increase In Incidence Of Cardiovascular Diseases To Drive Market

Cerebral Somatic Oximeters Market – Snapshot

Cerebral somatic oximeter is also known as regional oximeter. Cerebral oximeters provide clinicians reliable and efficient patient monitoring to help prevent adverse events. These devices are used to monitor oxygen saturation (rSO2).
Neurological diseases and brain trauma such as hypoxic-ischemic encephalopathy (HIE) are caused due to less supply of oxygen to the brain. Hence, increase in incidence of cerebral hypoxia is anticipated to drive demand for cerebral oximeters. According to WHO 2015 estimates, HIE occurs in about 2 to 9 per 1,000 live births and causes significant brain damage and impairment. Increase in incidence of neurological diseases and disorders is expected to drive the global cerebral somatic oximeters market. Rise in the number of product approvals is likely to fuel the growth of the global cerebral somatic oximeters market during the forecast period. In May 2017, Masimo received FDA clearance for the pediatric indication for O3 regional oximetry with the O3 pediatric sensor.
cerebral somatic oximeters market
The global cerebral somatic oximeters market has been segmented based on type, clinical application, patient type and end-user. In terms of type, the market has been classified into dual emitter and dual detector, single emitter and dual detector, and others. Based on clinical application, the market has been classified into cardiac surgery, vascular surgery, and others. Based on patient type, the market is classified as NICU, pediatrics, adults. In terms of end-user, the global cerebral somatic oximeters market has been categorized into hospitals, ambulatory surgical centers, clinics, and others. Based on region, the global market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Request the Coronavirus Impact Analysis across Industries and Markets- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=22739
In terms of type, the single emitter and dual detector segment is projected to expand at a high CAGR in the next few years. The segment is anticipated to account for major share of the market by 2026. Based on application, the cardiac surgery segment is expected to grow at a rapid pace from 2018 to 2026. Increase in patient population, rise in product approvals, and technological developments are likely to boost market growth during the forecast period.
North America dominated the global cerebral somatic oximeters market in 2017, followed by Europe and Asia Pacific. Popularity of pulse oximeters and cerebral devices, increase in demand for high quality treatment, and technological advancements drive the market in these regions. Moreover, rise in prevalence of diseases, favorable reimbursement policies, increase in the geriatric population, and surge in health care expenditure are projected to propel the market in these regions during the forecast period. Asia Pacific is expected to be the most lucrative market for cerebral somatic oximeters from 2018 to 2026. Increase in disposable income, rise in population, and expansion of key players in the region are likely to boost the growth of the market in Asia Pacific.
Key players operating in the global cerebral somatic oximeters market include Medtronic, Nonin Medical, CASMED, ISS, Inc., Masimo, Hamamatsu Photonics K.K., and Ornim Medical.

Cranial Implants Market:Value Added Features In Cranial Implants To Fuel Market

Cranial Implants Market – Snapshot

The global cranial implants market is expanding due to an increase in the number of brain cancer and trauma cases and rapid technological advancements for establishing effective and efficient treatment platforms for cranial reconstruction. The global cranial implants market was valued at more than US$ 792.0 Mn in 2017. It is projected to reach a value of US$ 1.4 Bn by 2026, expanding at a CAGR of more than 6.5% from 2018 to 2026. The global market is expanding at a relatively higher growth rate due to an increase in the geriatric population, rise in the prevalence of cancer and trauma cases, increase in the number of cranial surgeries, research and developmental activities in the health care sector in both developed and developing countries
cranial implants market
The human head can be subjected to several impactful loadings, such as those taking place due to falls, injuries, road accidents, etc.. These loadings may result in skull fracture, and in some cases, part of the skull may need to be replaced by a biomedical implant. Accidents may also lead to brain swelling, which can be treated by decompressive craniectomy.
Cranioplasty is a neurosurgical procedure that is used to repair cranial defects resulting due to traumatic brain injury (TBI), brain tumors, and hemorrhagic diseases. This procedure is conducted with the aid of cranial implants. Earlier, several different types of materials were used for cranioplasty. With technological advancements, new materials and technological interventions are available, providing specificity for the patient population according to the treatment and surgeon.
Increase in technological advancements, such as implant computer-aided design, 3-D printing, and regenerative medicine has resulted in the advent of 3-D-print patient-specific implants that can be made from a variety of materials, including polymer, ceramic, or metal. They are more effective and accurate for treatment and help surgeons achieve increased success rates. Also, factors such as a rise in the geriatric population, increase in demand for customized cranial implants, and rise in the number of injuries and road accidents are boosting the growth of the cranial implants market. Furthermore, an increase in research and development activities and studies and rise in awareness are also anticipated to boost the cranial implants market.
The global cranial implants market has been segmented based on product, material, end-user, and region. In terms of product, the market has been classified into customized cranial implants and non-customized cranial implants. The non-customized cranial implants segment is expected to hold a significant share of the market, while the customized cranial implants segment is expected to expand at a significant CAGR of 7.1% during the forecast period. Customized cranial implants are considered to be specific and well-fitted according to the cranial defects, save operating room procedure time and aid surgeons, may render the procedure less invasive, and reduce the risk of infection and complications. Generally, non-customized implants comprise traditional methods for cranial implantation. The number of non-customized implant products available in the market is higher.
Request the Coronavirus Impact Analysis across Industries and Markets- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=60159
In terms of material, the global cranial implants market has been classified into polymer, ceramic, and metal. The metal segment is projected to hold a prominent share of the market, while the polymer segment is anticipated to expand at a significant CAGR during the forecast period. The metal segment is estimated to expand at a CAGR of 6.8% during the forecast period. The most commonly used metal is grade 5 surgical titanium (i.e., Ti-6Al-4V), usually referred to as ‘titanium’ or Ti-6-4. Metal is used in the cranium for fixation devices (e.g., plates and screws), solid plates, or mesh, or in combination with other materials such as ceramic components or inert plastic. The availability and long-term success rates of metals such as titanium, specifically related to resistance to infections, have contributed to their leading position in the cranial implants market.
In terms of end-user, the global cranial implants market has been classified into hospitals and neurosurgery specialty centers. The hospitals segment is expected to dominate the market and expand at a CAGR of 6.9% during the forecast period. This is due to a rise in the number of hospitals, high surgery volume, and rise in the number of medical professionals.
Based on region, the global cranial implants market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global market and account for a prominent share in the coming years. The market in North America is primarily driven by a rapid increase in the geriatric population; rise in the patient population; high prevalence of trauma, injuries, road accidents, and brain cancer cases; and increase in the acceptance of technologically advanced cranial implants. Moreover, increase in awareness among people, rise in the number of players and products, and substantial focus on research and development are anticipated to fuel the global cranial implants market in North America during the forecast period. According to The American Association for the Surgery of Trauma (AAST), in the U.S., traumatic brain Injury (TBI) is the single largest cause of death from injury. The market in Asia Pacific is anticipated to expand at a rapid pace during the forecast period. The market in the region is estimated to be augmented by the presence of a large base of geriatric population, government initiatives in the health care field, expansion in research and development activities, and improving health care infrastructure.

tech